Bekim Lifesciences LLP
About Bekim Lifesciences LLP
Data last updated:
Bekim Lifesciences LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 May 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAM-7124. The LLP has 2 GST registrations on record, none of which is active.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Rishub Jain and Amit Gupta.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹23,438, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹89,797 (net margin -383.1%) and EBITDA of -₹1.87 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 88% over three years.
The LLP has about 2 employees on its provident fund (EPFO) records.
Company details
Contact details
Bekim Lifesciences LLP's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address1st Floor Kagalwala House Plot No. 175 Cst Road Kalina Bandra Kurla Complex Santacruz Ea, St, Mumbai, Maharashtra, India – 400098
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bekim Lifesciences LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bekim Lifesciences LLP
FY 2025 filings availableBekim Lifesciences LLP reported revenue of ₹23,438 (up 4% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 88%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | -₹89,797 | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | -383.1% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Bekim Lifesciences LLP, buy the company report.
Designated partners of Bekim Lifesciences LLP
Bekim Lifesciences has 4 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishub Jain Also directs: Benestar Healthcare LLP, C.T. Engineering Polymers Private Limited, GCD Resorts and Hotels Private Limited and 3 more | Designated Partner | 26 May 2018 | 8 Years 5 Months | Current |
| Amit Gupta Also directs: Benestar Healthcare LLP, Lalit Memorial Hospital Private Limited | Designated Partner | 16 Feb 2019 | 7 Years 8 Months | Current |
| Mayur Aggarwal Also directs: Benestar Healthcare LLP, Grand Tubes and Polymers Limited | Designated Partner | 16 Feb 2019 | 7 Years 8 Months | Current |
| Ravi Dalal | Designated Partner | 26 May 2018 | 8 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Bekim Lifesciences LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bekim Lifesciences LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bekim Lifesciences LLP has a workforce of 2 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
Bekim Lifesciences has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Bekim Lifesciences LLP, buy the company report.
Recent activity
Bekim Lifesciences LLP has 6 designated partner changes on record since 2018: 4 appointments and 2 cessations. The latest: Amit Gupta was appointed as Designated Partner on 16 Feb 2019.
Frequently asked questions
Bekim Lifesciences is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 26 May 2018 (8+ years old) and is registered under LLPIN AAM-7124.
Bekim Lifesciences has 4 current designated partners:
- Rishub Jain - Designated Partner
- Amit Gupta - Designated Partner
- Mayur Aggarwal - Designated Partner
- Ravi Dalal - Designated Partner
The latest financial statements of Bekim Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2019 are in the company report.
No. Bekim Lifesciences has 2 GST registrations on record and all of them are cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of Bekim Lifesciences is AAM-7124. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Bekim Lifesciences was incorporated on 26 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Amit Gupta was appointed as Designated Partner on 16 Feb 2019. Mayur Aggarwal was appointed as Designated Partner on 16 Feb 2019. Amit Gupta ceased to be Partner on 15 Feb 2019. Bekim Lifesciences has 6 designated partner changes on record in total.
The registered office of Bekim Lifesciences is at 1st Floor Kagalwala House Plot No. 175 Cst Road Kalina Bandra Kurla Complex Santacruz Ea, St, Mumbai, Maharashtra, India – 400098.
Bekim Lifesciences operates in the pharma industry, in the drug formulation and development segment.
Bekim Lifesciences can be reached at its registered office: 1st Floor Kagalwala House Plot No. 175 Cst Road Kalina Bandra Kurla Complex Santacruz Ea, St, Mumbai, Maharashtra, India – 400098.